Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.

Abrupt cuts by the Trump administration to the US National Institutes of Health threaten progress in medical research ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

As the Alamo undergoes restoration in honor of the 189th anniversary of the battle's end, "GMA" shares an exclusive look at ...

Labroots’ virtual events are designed to spark impactful scientific discussions while connecting with individuals worldwide ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS ...

The drug's use was also on the rise in places like New York, where, in the following year, at least 95% of those admitted to ...

Global AI in Drug Discovery Market is valued at USD 1.3 Billion in 2022. Global AI in Drug Discovery Market valuation to ...

Iambic, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, today announced its participation in the following investor conference ...